Mitch Unger is a seasoned Credit Analyst at T. Rowe Price, where he specializes in the health care sector, with a particular focus on medical technology companies. With a keen eye for identifying growth potential in challenging macroeconomic environments, Mitch provides valuable insights into how health care businesses can thrive even amid economic uncertainties. His analysis of the post-COVID landscape highlights the resilience and adaptability of medical technology firms, emphasizing their capacity for growth despite potential recessionary pressures. Mitch's expertise is grounded in over fifteen years of experience in financial analysis, during which he has developed a robust understanding of the factors driving health care and medical technology industries. His contributions are integral to T. Rowe Price's investment strategies, helping clients navigate and capitalize on opportunities in the evolving health care market. Mitch Unger's deep industry knowledge and forward-looking perspective make him a trusted advisor in the realm of credit analysis and health care investments.